Gadong, Baby Girl E.

HRN: 23-89-79  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/28/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/28/2023
11/04/2023
IV
30mg
Q24
PSNB
Waiting Final Action 
10/28/2023
AMPICILLIN 1GM (VIAL)
10/28/2023
11/04/2023
IV
30mg
Q12
PSNB
Waiting Final Action 
11/02/2023
CEFOTAXIME 500MG (VIAL)
11/02/2023
11/09/2023
IV
105mg
Q12hours
Neonatal Sepsis
Waiting Final Action 
11/02/2023
GENTAMICIN 40MG/ML, 2ML (AMP)
11/02/2023
11/09/2023
IV
10mg
OD
Neonatal Sepsis
Waiting Final Action 
11/07/2023
CEFTRIAXONE 1G (VIAL)
11/07/2023
11/13/2023
IV
170mg
OD
Neonatal Sepsis
Waiting Final Action 
11/12/2023
CEFTAZIDIME 1GM (VIAL)
11/12/2023
11/15/2023
IV
80mg
Q8h
Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: